CoChat
Sign Up
Cited by 10

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Advancing T-cell immunotherapy for cellular senescence and disease: Mechanisms, challenges, and clinical prospects

Wu, Jizhun, Zhang, Lu, Zhao, Zihan, Liu, Yuping, Li, Zhengxing, Feng, Xiaohang, Zhang, Lin, Yao, Xiang, Du, Jun, Chen, Liang, Zhou, Zhuolong·2025·Ageing Research Reviews
DOI 10.1016/j.arr.2025.102783
Open this paper in CoChat — free account

Abstract

Cellular senescence is a complex biological process with a dual role in tissue homeostasis and aging-related pathologies. Accumulation of senescent cells promotes chronic inflammation, tissue dysfunction, age-related diseases, and tumor suppression. Recent advancements in immunotherapy have positioned T cell-based approaches as precision tools for the targeted clearance of senescent cells, offering a novel avenue for anti-aging interventions. This review explores the molecular mechanisms underlying cellular senescence, focusing on its immunogenic features and interactions with T cells, including T-cell activation, antigen recognition, modulation of tumor microenvironment (TME), and immune evasion strategies. Innovations such as chimeric antigen receptor (CAR)-T cells, immune checkpoint therapies, and SASP-neutralizing approaches are highlighted as breakthrough strategies for enhancing senescent cell eradication. The integration of multi-omics and artificial intelligence is further catalyzing the development of personalized therapies to amplify immune surveillance and tissue rejuvenation. Clinically, T cell-based interventions hold promise for mitigating age-related pathologies and extending healthspan, yet challenges remain in optimizing target specificity, countering immunosuppressive niches, and overcoming immune senescence in aging populations. This review synthesizes current advances and challenges, highlighting the potential of T cell immunotherapy as a cornerstone of an…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.arr.2025.102783

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 48 references

Research works printed but not linked: 126

  1. Aguayo-Mazzucato, 2019, Acceleration of beta cell aging determines diabetes and senolysis improves disease outcomes, Cell Metab., 30, 129, 10.1016/j.cmet.2019.05.006 · DOI · Paper page
  2. Amor, 2024, Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction, Nat. Aging, 4, 336, 10.1038/s43587-023-00560-5 · DOI · Paper page
  3. Andreu-Saumell, 2024, CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition, Nat. Commun., 15, 3552, 10.1038/s41467-024-47799-z · DOI
  4. Anon, 2018, Theme 9 Clinical trials and trial design, Amyotroph. Lateral Scler. Frontotemp. Degener., 19, 264, 10.1080/21678421.2018.1510576 · DOI
  5. Baechle, 2023, Chronic inflammation and the hallmarks of aging, Mol. Metab., 74, 10.1016/j.molmet.2023.101755 · DOI · Paper page
  6. Baumeister, 2019, Phase I trial of autologous CAR T cells targeting NKG2D ligands in patients with AML/MDS and multiple myeloma, Cancer Immunol. Res., 7, 100, 10.1158/2326-6066.CIR-18-0307 · DOI
  7. Beers, 2022, Tregs attenuate peripheral oxidative stress and acute phase proteins in ALS, Ann. Neurol., 92, 195, 10.1002/ana.26375 · DOI
  8. Belle, 2024, Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer, Cancer Discov., 14, 1324, 10.1158/2159-8290.CD-23-0428 · DOI
  9. Bitencourt, 2024, Subcellular structure, heterogeneity, and plasticity of senescent cells, Aging Cell, 23, 10.1111/acel.14154 · DOI
  10. Bjorkegren, 2022, Atherosclerosis: recent developments, Cell, 185, 1630, 10.1016/j.cell.2022.04.004 · DOI
  11. Bloom, 2023, Mechanisms and consequences of endothelial cell senescence, Nat. Rev. Cardiol., 20, 38, 10.1038/s41569-022-00739-0 · DOI
  12. Bordon, 2023, T cells target viral protein to remove senescent fibroblasts, Nat. Rev. Immunol., 23, 271
  13. Bosenberg, 2023, Mouse models for immuno-oncology, Trends Cancer, 9, 578, 10.1016/j.trecan.2023.03.009 · DOI
  14. Brown, 2016, Regression of glioblastoma after chimeric antigen receptor T-cell therapy, N. Engl. J. Med., 375, 2561, 10.1056/NEJMoa1610497 · DOI
  15. Budhu, 2014, The importance of animal models in tumor immunity and immunotherapy, Curr. Opin. Genet. Dev., 24, 46, 10.1016/j.gde.2013.11.008 · DOI
  16. Calcinotto, 2019, Cellular senescence: aging, cancer, and injury, Physiol. Rev., 99, 1047, 10.1152/physrev.00020.2018 · DOI · Paper page
  17. Camell, 2021, Senolytics reduce coronavirus-related mortality in old mice, Science, 373, 10.1126/science.abe4832 · DOI · Paper page
  18. Carr, 2017, Vitamin C and immune function, Nutrients, 9, 10.3390/nu9111211 · DOI · Paper page
  19. Carrasco, 2022, The role of T cells in age-related diseases, Nat. Rev. Immunol., 22, 97, 10.1038/s41577-021-00557-4 · DOI
  20. Chang, 2015, Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy, J. Cell. Physiol., 230, 1567, 10.1002/jcp.24903 · DOI
  21. Chen, 2023, Senescence rewires microenvironment sensing to facilitate antitumor immunity, Cancer Discov., 13, 432, 10.1158/2159-8290.CD-22-0528 · DOI
  22. Childs, 2015, Cellular senescence in aging and age-related disease: from mechanisms to therapy, Nat. Med., 21, 1424, 10.1038/nm.4000 · DOI · Paper page
  23. Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science, 354, 472, 10.1126/science.aaf6659 · DOI · Paper page
  24. Chondronasiou, 2022, Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming, Aging Cell, 21, 10.1111/acel.13578 · DOI · Paper page
  25. Coppe, 2010, The senescence-associated secretory phenotype: the dark side of tumor suppression, Annu. Rev. Pathol., 5, 99, 10.1146/annurev-pathol-121808-102144 · DOI · Paper page
  26. Coryell, 2021, Mechanisms and therapeutic implications of cellular senescence in osteoarthritis, Nat. Rev. Rheumatol., 17, 47, 10.1038/s41584-020-00533-7 · DOI · Paper page
  27. De Henau, 2016, Overcoming resistance to checkpoint blockade therapy by targeting PI3Kgamma in myeloid cells, Nature, 539, 443, 10.1038/nature20554 · DOI
  28. Dehkordi, 2021, Profiling senescent cells in human brains reveals neurons with CDKN2D/p19 and tau neuropathology, Nat. Aging, 1, 1107, 10.1038/s43587-021-00142-3 · DOI · Paper page
  29. Dellago, 2013, High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan, Aging Cell, 12, 446, 10.1111/acel.12069 · DOI
  30. Dong, 2021, The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes, JCI Insight, 6, 10.1172/jci.insight.147474 · DOI
  31. Dong, 2024, Cellular senescence and SASP in tumor progression and therapeutic opportunities, Mol. Cancer, 23, 181, 10.1186/s12943-024-02096-7 · DOI
  32. Elyahu, 2019, Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes, Sci. Adv., 5, eaaw8330, 10.1126/sciadv.aaw8330 · DOI · Paper page
  33. Elyaman, 2025, Exploring the role of T cells in Alzheimer's and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposium, Alzheimers Dement., 21, 10.1002/alz.14548 · DOI
  34. Faridar, 2023, A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease, Transl. Neurodegener., 12, 54, 10.1186/s40035-023-00387-5 · DOI
  35. Farr, 2017, Targeting cellular senescence prevents age-related bone loss in mice, Nat. Med, 23, 1072, 10.1038/nm.4385 · DOI · Paper page
  36. Foote, 2025, Embracing generative artificial intelligence in clinical research and beyond: opportunities, challenges, and solutions, JACC Adv., 4, 10.1016/j.jacadv.2025.101593 · DOI
  37. Fu, 2023, The inter-link of ageing, cancer and immunity: findings from real-world retrospective study, Immun. Ageing, 20, 75, 10.1186/s12979-023-00399-9 · DOI
  38. Fullard, 2020, A review of the relationship between vitamin D and Parkinson disease symptoms, Front. Neurol., 11, 454, 10.3389/fneur.2020.00454 · DOI
  39. Fusi, 2023, Senescence-driven inflammatory and trophic microenvironment imprints mesenchymal stromal/stem cells in osteoarthritic patients, Biomedicines, 11, 10.3390/biomedicines11071994 · DOI
  40. Granit, 2023, Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study, Lancet Neurol., 22, 578, 10.1016/S1474-4422(23)00194-1 · DOI
  41. Grootaert, 2024, Cell senescence in cardiometabolic diseases, NPJ Aging, 10, 46, 10.1038/s41514-024-00170-4 · DOI
  42. Hasegawa, 2023, Cytotoxic CD4(+) T cells eliminate senescent cells by targeting cytomegalovirus antigen, Cell, 186, 1417, 10.1016/j.cell.2023.02.033 · DOI
  43. He, 2020, Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity, Nat. Commun., 11, 1996, 10.1038/s41467-020-15838-0 · DOI · Paper page
  44. He, 2017, Senescence in health and disease, Cell, 169, 1000, 10.1016/j.cell.2017.05.015 · DOI · Paper page
  45. Helman, 2016, p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion, Nat. Med., 22, 412, 10.1038/nm.4054 · DOI · Paper page
  46. Herdy, 2024, Neuronal senescence may drive brain aging, Science, 384, 1404, 10.1126/science.adi3450 · DOI
  47. Herr, 2024, Replication stress as a driver of cellular senescence and aging, Commun. Biol., 7, 616, 10.1038/s42003-024-06263-w · DOI
  48. Huang, 2022, Cellular senescence: the good, the bad and the unknown, Nat. Rev. Nephrol., 18, 611, 10.1038/s41581-022-00601-z · DOI · Paper page
  49. Jain, 2023, Heterogeneity of memory T cells in aging, Front. Immunol., 14, 1250916, 10.3389/fimmu.2023.1250916 · DOI
  50. Jiang, 2024, Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy, Semin. Cancer Biol., 101, 58, 10.1016/j.semcancer.2024.05.002 · DOI
  51. Kang, 2011, Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature, 479, 547, 10.1038/nature10599 · DOI · Paper page
  52. Kasakovski, 2018, T cell senescence and CAR-T cell exhaustion in hematological malignancies, J. Hematol. Oncol., 11, 91, 10.1186/s13045-018-0629-x · DOI
  53. Khoshandam, 2024, CRISPR, CAR-T, and NK: current applications and future perspectives, Genes Dis., 11
  54. Kim, 2013, Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role for reducing lipid accumulation, J. Biol. Chem., 288, 22693, 10.1074/jbc.M113.477505 · DOI
  55. Klein, 2016, Sex differences in immune responses, Nat. Rev. Immunol., 16, 626, 10.1038/nri.2016.90 · DOI · Paper page
  56. Kondoh, 2022, Targeting p21 for diabetes: another choice of senotherapy, Cell Metab., 34, 5, 10.1016/j.cmet.2021.12.008 · DOI
  57. Krizhanovsky, 2008, Senescence of activated stellate cells limits liver fibrosis, Cell, 134, 657, 10.1016/j.cell.2008.06.049 · DOI · Paper page
  58. Kroemer, 2022, Immunogenic cell stress and death, Nat. Immunol., 23, 487, 10.1038/s41590-022-01132-2 · DOI · Paper page
  59. Lelarge, 2024, Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment, NPJ Aging, 10, 12, 10.1038/s41514-024-00138-4 · DOI · Paper page
  60. Li, 2021, Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy, Cell Rep. Med., 2
  61. Li, 2023, Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering, Sci. Adv., 9, eadd6997, 10.1126/sciadv.add6997 · DOI
  62. Li, 2025, Regulatory T cells for stroke recovery: a promising immune therapeutic strategy, CNS Neurosci. Ther., 31, 10.1111/cns.70248 · DOI
  63. Li, 2020, A fresh approach to targeting aging cells: CAR-T cells enhance senolytic specificity, Cell Stem Cell, 27, 192, 10.1016/j.stem.2020.07.010 · DOI
  64. Liu, 2015, Human induced pluripotent stem cell and nanotechnology-based therapeutics, Cell Transpl., 24, 2185, 10.3727/096368914X685113 · DOI
  65. Lobo, 2017, Interventional procedures and future drug therapy for hypertension, Eur. Heart J., 38, 1101
  66. Lodka, 2024, CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury, Ann. Rheum. Dis., 83, 499, 10.1136/ard-2023-224875 · DOI
  67. Lopez-Otin, 2023, Meta-hallmarks of aging and cancer, Cell Metab., 35, 12, 10.1016/j.cmet.2022.11.001 · DOI · Paper page
  68. Majewska, 2024, p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells, Nat. Cell Biol., 26, 1336, 10.1038/s41556-024-01465-0 · DOI
  69. Manning, 2013, Vitamin C promotes maturation of T-cells, Antioxid. Redox Signal., 19, 2054, 10.1089/ars.2012.4988 · DOI
  70. Marin, 2023, Cellular senescence is immunogenic and promotes antitumor immunity, Cancer Discov., 13, 410, 10.1158/2159-8290.CD-22-0523 · DOI
  71. Martin-Antonio, 2024, Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations, Front. Immunol., 15, 1386856, 10.3389/fimmu.2024.1386856 · DOI
  72. Matsuda, 2008, CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system, Curr. Opin. Immunol., 20, 358, 10.1016/j.coi.2008.03.018 · DOI
  73. Matveeva, 2024, T-cell immunity against senescence: potential role and perspectives, Front. Immunol., 15, 1360109, 10.3389/fimmu.2024.1360109 · DOI
  74. McHugh, 2018, Senescence and aging: causes, consequences, and therapeutic avenues, J. Cell Biol., 217, 65, 10.1083/jcb.201708092 · DOI · Paper page
  75. Meng, 2024, Application of AI in biological age prediction, Curr. Opin. Struct. Biol., 85, 10.1016/j.sbi.2024.102777 · DOI
  76. Moller, 2022, Metabolic programs tailor T cell immunity in viral infection, cancer, and aging, Cell Metab., 34, 378, 10.1016/j.cmet.2022.02.003 · DOI
  77. Mossanen, 2019, CXCR6 inhibits hepatocarcinogenesis by promoting natural killer T- and CD4(+) T-cell-dependent control of senescence, Gastroenterology, 156, 1877, 10.1053/j.gastro.2019.01.247 · DOI
  78. Mottaghi, 2014, Vitamin A supplementation reduces IL-17 and RORc gene expression in atherosclerotic patients, Scand. J. Immunol., 80, 151, 10.1111/sji.12190 · DOI
  79. Nasiri, 2025, Mechanisms of antigen-dependent resistance to chimeric antigen receptor (CAR)-T cell therapies, Cancer Cell Int., 25, 64, 10.1186/s12935-025-03697-y · DOI
  80. Novais, 2021, Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice, Nat. Commun., 12, 5213, 10.1038/s41467-021-25453-2 · DOI · Paper page
  81. Oesterreich, 2023, Senescence and Immunotherapy: redundant Immunomodulatory Pathways Promote Resistance, Cancer Immunol. Res., 11, 401, 10.1158/2326-6066.CIR-23-0051 · DOI
  82. Ogrodnik, 2019, Obesity-induced cellular senescence drives anxiety and impairs neurogenesis, Cell Metab., 29, 1061, 10.1016/j.cmet.2018.12.008 · DOI · Paper page
  83. O'Neal, 2023, Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc, Blood Adv., 7, 6009, 10.1182/bloodadvances.2023010032 · DOI
  84. Onorati, 2022, Upregulation of PD-L1 in senescence and aging, Mol. Cell Biol., 42, 10.1128/mcb.00171-22 · DOI
  85. O'Sullivan, 2024, The paradox of senescent-marker positive cancer cells: challenges and opportunities, NPJ Aging, 10, 41, 10.1038/s41514-024-00168-y · DOI
  86. Pereira, 2020, Sestrins induce natural killer function in senescent-like CD8(+) T cells, Nat. Immunol., 21, 684, 10.1038/s41590-020-0643-3 · DOI
  87. Poorebrahim, 2021, Counteracting CAR T cell dysfunction, Oncogene, 40, 421, 10.1038/s41388-020-01501-x · DOI
  88. Prata, 2018, Senescent cell clearance by the immune system: emerging therapeutic opportunities, Semin. Immunol., 40, 10.1016/j.smim.2019.04.003 · DOI · Paper page
  89. Ravula, 2021, Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: an updated review, Eur. J. Pharm., 910, 10.1016/j.ejphar.2021.174492 · DOI
  90. Ray, 2018, Immune senescence, epigenetics and autoimmunity, Clin. Immunol., 196, 59, 10.1016/j.clim.2018.04.002 · DOI · Paper page
  91. Richards, 2007, Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women, Am. J. Clin. Nutr., 86, 1420, 10.1093/ajcn/86.5.1420 · DOI · Paper page
  92. Rim, 2024, Recent and anticipated novel drug approvals for 2024, Am. J. Health Syst. Pharm., 81, 385, 10.1093/ajhp/zxae046 · DOI
  93. Rivera, 2017, Hair repigmentation during immunotherapy treatment with an anti-programmed cell death 1 and anti-programmed cell death ligand 1 agent for lung cancer, JAMA Dermatol., 153, 1162, 10.1001/jamadermatol.2017.2106 · DOI
  94. Santos, 2017, Protein posttranslational modifications: roles in aging and age-related disease, Oxid. Med. Cell. Longev., 2017, 5716409, 10.1155/2017/5716409 · DOI
  95. Schwartz, 2020, T cells in autoimmunity-associated cardiovascular diseases, Front. Immunol., 11, 10.3389/fimmu.2020.588776 · DOI
  96. Soto-Palma, 2022, Epigenetics, DNA damage, and aging, J. Clin. Invest., 132, 10.1172/JCI158446 · DOI
  97. Srinivasan, 2021, Age-related changes in thymic central tolerance, Front. Immunol., 12, 10.3389/fimmu.2021.676236 · DOI
  98. Sterner, 2021, CAR-T cell therapy: current limitations and potential strategies, Blood Cancer J., 11, 69, 10.1038/s41408-021-00459-7 · DOI · Paper page
  99. Sun, 2019, Eradication of hepatocellular carcinoma by NKG2D-based CAR-T cells, Cancer Immunol. Res., 7, 1813, 10.1158/2326-6066.CIR-19-0026 · DOI
  100. Tao, 2024, Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies, Blood Cancer J., 14, 213, 10.1038/s41408-024-01193-6 · DOI
  101. Thompson, 2019, Targeted elimination of senescent beta cells prevents type 1 diabetes, Cell Metab., 29, 1045, 10.1016/j.cmet.2019.01.021 · DOI · Paper page
  102. Thonhoff, 2022, Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis, Neurol. Neuroimmunol. Neuroinflamm., 9, 10.1212/NXI.0000000000200019 · DOI
  103. Tie, 2022, Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets, J. Hematol. Oncol., 15, 61, 10.1186/s13045-022-01282-8 · DOI · Paper page
  104. Uryga, 2021, Telomere damage promotes vascular smooth muscle cell senescence and immune cell recruitment after vessel injury, Commun. Biol., 4, 611, 10.1038/s42003-021-02123-z · DOI · Paper page
  105. Victorelli, 2023, Apoptotic stress causes mtDNA release during senescence and drives the SASP, Nature, 622, 627, 10.1038/s41586-023-06621-4 · DOI
  106. Wang, 2012, Epigallocatechin-3-gallate inhibits expression of receptors for T cell regulatory cytokines and their downstream signaling in mouse CD4+ T cells, J. Nutr., 142, 566, 10.3945/jn.111.154419 · DOI
  107. Wang, 2021, Ginsenoside extract from ginseng extends lifespan and health span in Caenorhabditis elegans, Food Funct., 12, 6793, 10.1039/D1FO00576F · DOI
  108. Wang, 2022, Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes, Nature, 611, 358, 10.1038/s41586-022-05388-4 · DOI · Paper page
  109. Wang, 2024, Rejuvenation strategy for inducing and enhancing autoimmune response to eliminate senescent cells, Aging Dis.
  110. Wei, 2017, Nutrient and metabolic sensing in T cell responses, Front Immunol., 8, 247, 10.3389/fimmu.2017.00247 · DOI
  111. Wendimu, 2022, Microglia phenotypes in aging and neurodegenerative diseases, Cells, 11, 10.3390/cells11132091 · DOI · Paper page
  112. Wiley, 2021, The metabolic roots of senescence: mechanisms and opportunities for intervention, Nat. Metab., 3, 1290, 10.1038/s42255-021-00483-8 · DOI · Paper page
  113. Wu, 2024, Roles of chromatin and genome instability in cellular senescence and their relevance to ageing and related diseases, Nat. Rev. Mol. Cell Biol., 25, 979, 10.1038/s41580-024-00775-3 · DOI · Paper page
  114. Yang, 2023, NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates, Sci. Transl. Med., 15, eadd1951, 10.1126/scitranslmed.add1951 · DOI · Paper page
  115. Yin, 2022, Senescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance, Genes Dev., 36, 533, 10.1101/gad.349585.122 · DOI
  116. Yin, 2024, Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer, BMC Cancer, 24, 486, 10.1186/s12885-024-12228-3 · DOI
  117. Yosef, 2017, p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling, EMBO J., 36, 2280, 10.15252/embj.201695553 · DOI · Paper page
  118. Zhai, 2024, Cardiomyocyte senescence and the potential therapeutic role of senolytics in the heart, J. Cardiovasc Aging, 4, 10.20517/jca.2024.06 · DOI
  119. Zhang, 2023, Targeting cellular senescence with senotherapeutics: senolytics and senomorphics, FEBS J., 290, 1362, 10.1111/febs.16350 · DOI
  120. Zhang, 2021, Hallmarks of the aging T-cell system, FEBS J., 288, 7123, 10.1111/febs.15770 · DOI
  121. Zhao, 2018, Universal CARs, universal T cells, and universal CAR T cells, J. Hematol. Oncol., 11, 132, 10.1186/s13045-018-0677-2 · DOI
  122. Zhao, 2019, Dendrobium officinale polysaccharides protect against MNNG-induced PLGC in rats via activating the NRF2 and antioxidant enzymes HO-1 and NQO-1, Oxid. Med. Cell. Longev., 2019, 9310245, 10.1155/2019/9310245 · DOI
  123. Zhao, 2021, Immunomodulatory function of vitamin D and its role in autoimmune thyroid disease, Front. Immunol., 12
  124. Zhao, 2023, Dendrobium officinale polysaccharide converts M2 into M1 subtype macrophage Polarization via the STAT6/PPAR-r and JAGGED1/NOTCH1 signaling pathways to inhibit gastric cancer, Molecules, 28, 10.3390/molecules28207062 · DOI
  125. Zhu, 2016, Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors, Aging Cell, 15, 428, 10.1111/acel.12445 · DOI · Paper page
  126. Zingoni, 2024, The senescence journey in cancer immunoediting, Mol. Cancer, 23, 68, 10.1186/s12943-024-01973-5 · DOI

Cited by

Sorted by citations

See all 10

Metadata

Authors
Wu, J., Zhang, L., Zhao, Z., Liu, Y., Li, Z., Feng, X., Zhang, L., Yao, X., Du, J., Chen, L., & Zhou, Z.
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2025-07
Volume
109
Pages
102783
ISSN
1568-1637
DOI
10.1016/j.arr.2025.102783
Cited by
10
References
48
Language
en
Licence
Funders
  • Natural Science Foundation of Shenzhen Municipality (JCYJ20241202124303005)
  • University of Edinburgh
  • Zhejiang Province Natural Science Foundation (LHDMZ25H160001)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review